Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

179.05USD
27 Oct 2016
Change (% chg)

-- (--)
Prev Close
$179.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
165
52-wk High
$195.20
52-wk Low
$147.84

LZAGF.PK

Chart for LZAGF.PK

About

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a... (more)

Overall

Beta: 1.20
Market Cap(Mil.): CHF9,615.59
Shares Outstanding(Mil.): 52.92
Dividend: 2.50
Yield (%): 1.38

Financials

  LZAGF.PK Industry Sector
P/E (TTM): 26.54 42.21 29.87
EPS (TTM): 6.85 -- --
ROI: 7.45 -1.09 14.95
ROE: 17.20 -2.39 16.29

BRIEF-Lonza Group expects to reach 2018 guidance year early

* Says strong momentum in q3 gives us confidence to specify that core ebit is on track to cross 15% growth line for full-year 2016

Oct 27 2016

BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing

* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing

Oct 04 2016

Lonza buys InterHealth in health push

ZURICH Swiss specialty chemicals and pharmaceutical ingredients company Lonza has announced a deal worth up to $300 million to buy InterHealth Nutraceuticals, a developer and manufacturer of nutritional ingredients used in dietary supplements.

Aug 15 2016

Lonza buys InterHealth in health push

* Lonza to spend up to $300 million on health-supplements target

Aug 15 2016

European shares rise on strong results from SAP and Lonza

LONDON, July 20 European shares edged up in early trade on Wednesday, with Swiss speciality chemicals and life sciences group Lonza and software firm SAP leading the market higher after reporting solid results.

Jul 20 2016

Lonza raises outlook after double-digit core earnings rise in H1

ZURICH, July 20 Swiss speciality chemicals and life sciences group Lonza raised its guidance for 2016 after reporting the strongest earnings growth in its history during the first six month.

Jul 20 2016

BRIEF-Lonza raises guidance for core EBIT growth in 2016

* Raising its guidance for core ebit growth and now expects a double-digit improvement in core ebit for full year of 2016

Jul 20 2016

Earnings vs. Estimates